Recent epidemiologic evidence suggests that cancer survivors possess a lower risk of developing dementia. However, scientists are only now uncovering the specific biological drivers of this inverse relationship. A significant study recently published in the *Journal of Neuropathology & Experimental Neurology* identifies the **GRN rs5848 variant** as a key genetic factor. Specifically, the T allele of this variant increases the odds of neurodegenerative conditions while simultaneously reducing the risk of cancer. This discovery provides a molecular basis for clinical observations that have puzzled physicians for decades.

Understanding the Role of the GRN rs5848 Variant

The Granulin (GRN) gene encodes progranulin (PGRN), a protein that plays a dual role in the body. PGRN acts as a neuroprotective agent in the brain but also functions as a mitogen that can stimulate tumor growth. Consequently, the T allele of the **GRN rs5848 variant** leads to lower expression of progranulin. While this lower expression safeguards against neoplasia, it unfortunately leaves the brain vulnerable to limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and hippocampal sclerosis of aging (HS-Aging).

Moreover, the research utilized data from over 11,000 individuals within the Alzheimer’s Disease Genomics Consortium and Sequencing Project. The results confirmed that the T allele was associated with higher odds of LATE-NC (p < 0.001). Conversely, the same allele correlated with significantly lower odds of any cancer history (p = 0.002). Therefore, progranulin levels serve as a critical pivot point between neurodegeneration and cancer risk.

Clinical Implications for Physicians

Clinicians managing geriatric patients should recognize these findings as a step toward personalized medicine. Additionally, the study emphasizes that genetic predispositions often carry trade-offs between different disease states. Future therapies targeting progranulin must balance these risks carefully to avoid unintended oncogenic or neurodegenerative side effects.

Frequently Asked Questions

How does the GRN rs5848 variant influence dementia risk?

The T allele of this variant reduces the production of progranulin. Because progranulin protects neurons, its reduction increases the risk of TDP-43 brain pathology and hippocampal sclerosis.

Why is there an inverse relationship between cancer and dementia?

This relationship occurs because certain growth factors, like progranulin, promote cell survival. High levels may fuel cancer growth but protect the brain, while low levels (caused by variants like rs5848) prevent cancer but lead to neurodegeneration.

Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Aung KZ et al. GRN rs5848 variant associates with TDP-43 pathology and cancer in opposite directions. J Neuropathol Exp Neurol. 2026 May 21. doi: undefined. PMID: 42168777.

Hsiung GY et al. rs5848 polymorphism and serum progranulin level. J Neuropathol Exp Neurol. 2011. doi: 10.1097/NEN.0b013e3182104085.

National Alzheimer’s Coordinating Center. Genetic associations in age-related neuropathology datasets. [Accessed May 2026].